CRYL1 and atherosclerosis: Pharmacological activation of CRY proteins [with KL001 (24)] attenuates inflammatory responses in FLSs, in keeping with recent findings in a model of atherosclerosis, where overexpression of CRY1 had anti-inflammatory effects (41).